Algry Quimica Sees Boost in Choline Sales

Algry Quimica Sees Boost in Choline Sales

MADRID, Spain--Algry Quimica, a companyspecializing in choline derivatives for nutraceutical, food and pharmaceuticaluses, reported its sales rose 65 percent in 2002 over 2001 results. According tothe company, this increase was due to the United States expanding policiesregarding choline and an increase in exports to nutritional and nutraceuticalcompanies worldwide--especially to Europe as well as North and South America.

Algry Quimica (www.algry.com)also reported making further investments at its choline salts facility in Heulva,Spain, boosting manufacturing capabilities.